These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24167125)

  • 1. Diagnostic value of B-RAF(V600E) in difficult-to-diagnose thyroid nodules using fine-needle aspiration: systematic review and meta-analysis.
    Jia Y; Yu Y; Li X; Wei S; Zheng X; Yang X; Zhao J; Xia T; Gao M
    Diagn Cytopathol; 2014 Jan; 42(1):94-101. PubMed ID: 24167125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
    Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
    Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
    Trimboli P; Scappaticcio L; Treglia G; Guidobaldi L; Bongiovanni M; Giovanella L
    Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF
    Jinih M; Foley N; Osho O; Houlihan L; Toor AA; Khan JZ; Achakzai AA; Redmond HP
    Eur J Surg Oncol; 2017 Jul; 43(7):1219-1227. PubMed ID: 27923591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF
    Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY; Shin JH; Ko EY; Han BK
    AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.
    Kwak JY; Han KH; Yoon JH; Kim EK; Moon HJ; Kim YL; Park SJ; Choi JR
    Ann Clin Lab Sci; 2012; 42(3):258-65. PubMed ID: 22964613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH; Baek JH; Lee JH; Choi YJ; Ha EJ; Song DE; Kim JK; Chung KW; Kim TY; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
    Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ; Kim EK; Kwak JY
    Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
    Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
    Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.
    Koh J; Choi JR; Han KH; Kim EK; Yoon JH; Moon HJ; Kwak JY
    PLoS One; 2013; 8(5):e64505. PubMed ID: 23717622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule.
    Kang G; Cho EY; Shin JH; Chung JH; Kim JW; Oh YL
    Cancer Cytopathol; 2012 Feb; 120(1):44-51. PubMed ID: 21751431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of multi-gene testing in benign or malign diagnosis of thyroid nodules with indeterminate cytology].
    Song YT; Xu GH; Zhu YL; Ma TH; Yu H; Wang TX; Yu WB; Wei W; Zhang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 54(10):764-768. PubMed ID: 31606990
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules.
    Yeo MK; Liang ZL; Oh T; Moon Y; An S; Kim MK; Kim KS; Shong M; Kim JM; Jo YS
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):555-60. PubMed ID: 21609347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF
    Zhao CK; Zheng JY; Sun LP; Xu RY; Wei Q; Xu HX
    Cancer Med; 2019 Sep; 8(12):5577-5589. PubMed ID: 31397092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical role of BRAF V600E mutation testing in thyroid nodules].
    Wan H; Zhang B; Wang Y; Xiao T; Guo H; Liu W; Yan D; Xu Z; Tang P
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 49(6):468-72. PubMed ID: 25241863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
    Li X; Du H; Luo J; Ding W; Lai B; He J; Xu S; Zhang Y
    J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
    Cui Y; Huang X; Guo J; Zhang N; Liang J; Zhang Y; Liao Y; He D
    Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.